Presence of PIVKA II at day 5: 0.2 mg IV versus 0.2 mg IM · preterm infants
Intramuscular vitamin K showed no clear difference in presence of PIVKA II at day 5: 0.2 mg IV versus 0.2 mg IM compared with intravenous vitamin K (low certainty).
1 finding from 1 review
Presence of PIVKA II at day 5: 0.2 mg IV versus 0.5 mg IM · preterm infants
Intramuscular vitamin K showed no clear difference in presence of PIVKA II at day 5: 0.2 mg IV versus 0.5 mg IM compared with intravenous vitamin K (low certainty).
1 finding from 1 review
Presence of PIVKA II at day 25: 0.2 mg IV versus 0.2 mg IM · preterm infants
Intramuscular vitamin K showed no clear difference in presence of PIVKA II at day 25: 0.2 mg IV versus 0.2 mg IM compared with intravenous vitamin K (low certainty).
1 finding from 1 review
Presence of PIVKA II at day 25 ‐ 0.2 mg IV versus 0.5 mg IM · preterm infants
Intramuscular vitamin K showed no clear difference in presence of PIVKA II at day 25 ‐ 0.2 mg IV versus 0.5 mg IM compared with intravenous vitamin K (low certainty).
1 finding from 1 review
Necrotizing enterocolitis ‐ 0.2 mg IV versus 0.2 mg IM · preterm infants
Intramuscular vitamin K showed no clear difference in necrotizing enterocolitis ‐ 0.2 mg IV versus 0.2 mg IM compared with intravenous vitamin K (low certainty).
1 finding from 1 review
Bone mineral content at the end of intervention mg/cmPhoton absorptiometry · term breastfed infants to prevent vitamin D deficiency and improve bone health
1 finding from 1 review
Nutritional rickets ‐ biochemical Alkaline phosphatase, calcium and phosphate levels. · term breastfed infants to prevent vitamin D deficiency and improve bone health
1 finding from 1 review
Hypercalcaemia · term breastfed infants to prevent vitamin D deficiency and improve bone health
Vitamin D given to infants showed no clear difference in adverse effects (hypercalcaemia) compared with placebo or no treatment (low certainty).
1 finding from 1 review
Nutritional rickets ‐ radiological · term breastfed infants to prevent vitamin D deficiency and improve bone health
It is very uncertain whether vitamin D given to lactating mothers changes nutritional rickets ‐ radiological compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Hypercalcaemia · term breastfed infants to prevent vitamin D deficiency and improve bone health
Vitamin D given to lactating mothers showed no clear difference in adverse effects (hypercalcaemia) compared with placebo or no treatment (low certainty).
1 finding from 1 review
Nutritional rickets ‐ biochemical Alkaline phosphatase, calcium and phosphate levels. · term breastfed infants to prevent vitamin D deficiency and improve bone health
Vitamin D given to lactating mothers may leads to lower nutritional rickets ‐ biochemical Alkaline phosphatase, calcium and… compared with placebo or no treatment (low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality: longest · infants 1 to 6 months of age
The intervention showed no clear difference in all‐cause mortality: longest (moderate certainty).
1 finding from 1 review
Intervention not reported
Morbidity: diarrhoea: point prevalence · infants 1 to 6 months of age
The intervention showed no clear difference in morbidity: diarrhoea: point prevalence (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: bulging fontanelle within 48 to 72 hours · infants 1 to 6 months of age
The intervention leads to higher adverse effects: bulging fontanelle within 48 to 72 hours (high certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: vomiting 48 to 72 hours · infants 1 to 6 months of age
The intervention showed no clear difference in adverse effects: vomiting 48 to 72 hours (low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: diarrhoea 48 to 72 hours · infants 1 to 6 months of age
The intervention showed no clear difference in adverse effects: diarrhoea 48 to 72 hours (low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: fever 48 to 72 hours · infants 1 to 6 months of age
The intervention showed no clear difference in adverse effects: fever 48 to 72 hours (low certainty).
1 finding from 1 review